Skip to content
No results
  • News
  • Press Releases
  • Business
  • Research
  • Regulatory
  • Events and Conferences

Preventive Medicine 2023

We use cookies to ensure that we give you the best experience on our website.
  • About Us
  • Contact Us
the-pharma-data-logo-color

Preventive Medicine 2023

  • News
  • Press Releases
  • Business
  • Research
  • Regulatory
  • Events and Conferences
the-pharma-data-logo-color
  • Research

BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson’s disease clinical trial

  • ByThe Pharma Data
  • OnMarch 14, 2023

Rune Labs’ StriveStudy platform and Emerald Innovations’ Emerald wireless monitoring sensor will passively capture data on Parkinson’s disease impact on function of fifty study participants in BlueRock’s global non-interventional clinical…

Read More
  • Business

China National Medical Products Administration accepts regulatory submission for Nucala (mepolizumab) in severe eosinophilic asthma

  • ByThe Pharma Data
  • OnMarch 14, 2023

GSK plc (LSE/NYSE: GSK) today announced that the China National Medical Products Administration has accepted for review a new drug application for Nucala (mepolizumab) as an add-on maintenance treatment for severe eosinophilic…

Read More
  • Research

GSK announces positive pivotal phase III data for 5-in-1 Meningococcal ABCWY vaccine candidate

  • ByThe Pharma Data
  • OnMarch 14, 2023

GSK plc (LSE/NYSE: GSK) today announced positive headline results from the phase III trial (NCT04502693) evaluating the safety, tolerability, and immunogenicity of its MenABCWY combination vaccine candidate, administered as two…

Read More
  • News

Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved in Brazil for Use Regardless of Prior Dengue Exposure

  • ByThe Pharma Data
  • OnMarch 14, 2023

 Takeda (TSE:4502/NYSE:TAK) today announced the company’s dengue vaccine, QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003), was approved in Brazil by the National Health Surveillance Agency (ANVISA) for the prevention of dengue caused by…

Read More
  • Business

Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)

  • ByThe Pharma Data
  • OnMarch 14, 2023

Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which…

Read More
  • Business

Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

  • ByThe Pharma Data
  • OnMarch 11, 2023

ZAVZPRET is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal sprayfor the acute treatment of migraine in adults Expands Pfizer’s migraine portfolio, which includes an oral therapy…

Read More
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
  • Business

Astellas and Seagen Announce China’s National Medical Products Administration Accepts Biologics License Application for Enfortumab Vedotin in Certain Patients with Locally Advanced or Metastatic Urothelial Cancer

  • ByThe Pharma Data
  • OnMarch 11, 2023

Clinical data submitted are consistent with global data and support enfortumab vedotin as a platinum-free option in patients with locally advanced or metastatic urothelial cancer who received prior treatment with…

Read More
  • News

KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Advanced Malignant Pleural Mesothelioma

  • ByThe Pharma Data
  • OnMarch 11, 2023

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and the Canadian Cancer Trials Group (CCTG) today announced that the Phase 2/3 CCTG IND.227/KEYNOTE-483 trial evaluating…

Read More
  • Research

Engineered bacteria find tumors, then alert the authorities

  • ByThe Pharma Data
  • OnMarch 10, 2023

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of “bacterial suicide squad” that targets tumors, attracting the host’s own immune cells to…

Read More
  • News

Massive efforts needed to reduce salt intake and protect lives

  • ByThe Pharma Data
  • OnMarch 10, 2023

A first-of-its-kind World Health Organization (WHO) Global report on sodium intake reduction shows that the world is off-track to achieve its global target of reducing sodium intake by 30% by 2025.  Sodium,…

Read More
  • News

AskBio Announces Gustavo Pesquin as New CEO

  • ByThe Pharma Data
  • OnMarch 10, 2023

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that Gustavo Pesquin will become the company’s next Chief Executive Officer (CEO) as of…

Read More
  • Research

First nasal monoclonal antibody treatment for COVID-19 shows promise for treating virus, other diseases

  • ByThe Pharma Data
  • OnMarch 10, 2023

A pilot trial by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the drug Foralumab, an anti-CD3…

Read More
Prev
1 2 3 4 5 6 7 … 106
Next
Pediatric Academic Societies Meetimg (PAS) 2023
Global Pharma & Drug Delivery Summit 2023
ACPM 2023
ECBIP 2023
The 15th Paris Hepatology Conference 2023
ASGBI annual conference 2023
37th NASPAG Annual Clinical & Research Meeting 2023
18th Congress MESOT 2023
AMGA’s 2023 Annual Conference (AC23) 

About

The Pharma Data Is An Information-Centric Website Focused Mainly On The Pharmaceutical Industry Online It Is A B2B Platform Mainly Focused On The Latest Pharmaceutical News, Press Release, Industry-Related Updates, Events, And Conferences. With The Pharma Data, You Can Get All Information That Happens In The Pharmaceutical Industry.

Advertise With Us: marketing@thepharmadata.com

Quick Links

  • News
  • Press Releases
  • Business
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • Privacy Policy
  • Disclaimer
  • Terms and Conditions

Copyright © 2023 | The Pharma Data | Marnet Technologies Pvt Ltd. | Al Rights Reserved

Facebook Twitter LinkedIn